We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Purdue Pharma has requested permission from the U.S. Bankruptcy Court for the Southern District of New York to develop a new product to reverse opioid overdoses. A hearing before the court has been set for Feb. 21. Read More
In observance of Presidents' Day, Drug Industry Daily will not be published Monday, Feb. 17. The next issue will be published Tuesday, Feb. 18. Read More
Janssen Pharmaceuticals is joining forces with HHS to develop a vaccine candidate for COVID-19 and the Johnson and Johnson subsidiary is prepared to produce it on a large scale. Read More
Amgen is calling for a jury trial for Hospira in the U.S. District Court for the District of Delaware, alleging that the Pfizer subsidiary’s proposed Neulasta (pegfilgrastim) biosimilar infringed on its patents for the anti-infection drug. Read More
HHS Secretary Alex Azar defended the administration’s proposed fiscal 2021 budget before the Senate Finance Committee yesterday and noted that the budget “supports quick congressional action” to lower the cost of prescription drugs. Read More
The FDA cited a combination drug-device product manufacturer in China for serious testing failures and other violations uncovered in an inspection of its facility northwest of Shanghai. Read More
Mallinckrodt is facing another class-action suit over the price of its H.P. Acthar Gel (repository corticotropin), this time from the city of Marietta, Georgia. Read More